DK2099462T3 - Farmaceutisk præparat til behandling af inflammatoriske sygdomme i urogenitalkanalen - Google Patents

Farmaceutisk præparat til behandling af inflammatoriske sygdomme i urogenitalkanalen

Info

Publication number
DK2099462T3
DK2099462T3 DK07818284.7T DK07818284T DK2099462T3 DK 2099462 T3 DK2099462 T3 DK 2099462T3 DK 07818284 T DK07818284 T DK 07818284T DK 2099462 T3 DK2099462 T3 DK 2099462T3
Authority
DK
Denmark
Prior art keywords
treatment
kda
molecular weight
average molecular
chondroitin sulfate
Prior art date
Application number
DK07818284.7T
Other languages
English (en)
Inventor
Anna-Maria Vestweber
Original Assignee
Farco Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farco Gmbh filed Critical Farco Gmbh
Application granted granted Critical
Publication of DK2099462T3 publication Critical patent/DK2099462T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK07818284.7T 2006-12-12 2007-09-20 Farmaceutisk præparat til behandling af inflammatoriske sygdomme i urogenitalkanalen DK2099462T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006058776 2006-12-12
DE102006060953A DE102006060953A1 (de) 2006-12-12 2006-12-20 Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
PCT/EP2007/008194 WO2008071245A1 (de) 2006-12-12 2007-09-20 Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes

Publications (1)

Publication Number Publication Date
DK2099462T3 true DK2099462T3 (da) 2011-09-26

Family

ID=38820294

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07818284.7T DK2099462T3 (da) 2006-12-12 2007-09-20 Farmaceutisk præparat til behandling af inflammatoriske sygdomme i urogenitalkanalen

Country Status (7)

Country Link
EP (1) EP2099462B1 (da)
AT (1) ATE511847T1 (da)
DE (2) DE102006060953A1 (da)
DK (1) DK2099462T3 (da)
PL (1) PL2099462T3 (da)
SI (1) SI2099462T1 (da)
WO (1) WO2008071245A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009035586A1 (de) * 2009-07-31 2011-02-03 Fresenius Kabi Deutschland Gmbh Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs
FR2954340B1 (fr) * 2009-12-23 2013-02-01 Eads Europ Aeronautic Defence Revetement multifonctionnel pour aeronefs
IT1402382B1 (it) 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico
CN102210682B (zh) * 2011-04-29 2012-08-01 山东弘立医学动物实验研究有限公司 四氢嘧啶及其衍生物在制备治疗膀胱炎的药物中的应用
CN102258520B (zh) * 2011-04-29 2012-10-03 济南环肽医药科技有限公司 一种预防或治疗化疗引发的膀胱炎的药物组合物
DE202012000250U1 (de) 2011-11-24 2012-12-05 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Anwendung I
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
RU2519010C1 (ru) * 2013-03-20 2014-06-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Композиция для лечения цистита
FR3020570B1 (fr) 2014-04-30 2017-07-21 Pierre Fabre Dermo-Cosmetique Association d'un acide hyaluronique et d'un polysaccharide sulfate
CN105982912A (zh) * 2015-03-02 2016-10-05 黄绣川 一种包含透明质酸钠和硫酸软骨素的药物组合物
DE102016119183B4 (de) 2016-06-10 2019-05-16 Farco-Pharma Gmbh Medizinische Zusammensetzung, insbesondere in Form eines medizinischen Gels, und ihre Verwendung
EP3400949B1 (de) * 2017-05-12 2021-01-27 Farco-Pharma GmbH Zusammensetzung für die topische anwendung, insbesondere zur blaseninstillation
EP3400950B1 (de) * 2017-05-12 2019-11-13 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (20 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
EP3415163B1 (de) * 2017-06-13 2023-02-22 Farco-Pharma GmbH Zusammensetzung mit lokalanästhetischer wirkung und deren verwendung
CN113041405B (zh) * 2021-03-22 2022-06-10 山东华熙海御生物医药有限公司 一种含透明质酸和四氢嘧啶的人体润滑液及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4244580A1 (de) 1992-12-31 1994-07-07 Galinski Erwin A Verfahren zur in vivo Gewinnung von Inhaltsstoffen aus Zellen
IN181358B (da) 1995-02-14 1998-05-30 Bioniche Inc
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
US20020025921A1 (en) 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
DE69916643T2 (de) 1998-10-22 2005-04-28 Bioniche Life Sciences Inc., London Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
US6083933A (en) 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
AU2001281368B2 (en) * 2000-07-31 2005-07-28 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US7879824B2 (en) * 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
PT1708722E (pt) * 2004-01-28 2014-09-12 Univ California Nova terapia interstciial para o alívio imediato dos sintomas e terapia crónica na cistite intersticial
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes

Also Published As

Publication number Publication date
DE202007001059U1 (de) 2008-02-07
EP2099462B1 (de) 2011-06-08
EP2099462A1 (de) 2009-09-16
SI2099462T1 (sl) 2012-01-31
DE102006060953A1 (de) 2008-08-07
ATE511847T1 (de) 2011-06-15
WO2008071245A1 (de) 2008-06-19
PL2099462T3 (pl) 2011-11-30

Similar Documents

Publication Publication Date Title
DK2099462T3 (da) Farmaceutisk præparat til behandling af inflammatoriske sygdomme i urogenitalkanalen
KR101584824B1 (ko) 건성 점막 치료용 오스모라이트-함유 제제
RU2013125021A (ru) Местные композиции для сохранения или восстановления целостности слизистых оболочек
JP2004535430A5 (da)
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
WO2008103993A3 (en) Compositions and methods for treating glycogen storage diseases
ITMI20130075A1 (it) Combinazione orale per la prevenzione e il trattamento di patologie vescicali, pelviche e dell¿apparato uro-genitale
WO2009158625A3 (en) Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders
CA3019769C (en) Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
CA2632207C (en) Use of calcitonin for the treatment of ra
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
EP2251016B1 (en) Topical use of hyaluronic acid with filmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract.
JP2013510169A5 (da)
HRP20150949T1 (hr) UPORABA 24-norUDCA
FI2034956T4 (fi) Matalan viskositeetin omaavia glykosaminoglykaaneja käsittäviä koostumuksia ja mainitun koostumuksen käyttö kroonisen kystiitin terapiassa
WO2008073466A3 (en) Alpha b-crystallin as a therapy for inflammation
EP3548041A1 (en) Composition for the treatment of gastroesophageal reflux comprising hyaluronic acid
MD3905G2 (ro) Remediu medicamentos cu acţiune prelungită sub formă de gel pentru tratamentul afecţiunilor parodonţiului (variante)
JP2016196419A (ja) 皮膚外用製剤
KR20190124713A (ko) 염증성 장 질환 및 장 결장염을 치료하는데 사용하기 위한 조성물
CN103655601A (zh) 一种用于膀胱灌洗的组合物
RU2007129571A (ru) Композиции на основе солей гиалуроновой кислоты для лечения эпителиальных повреждений
RU2018125252A (ru) Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции
CA2516318A1 (en) Use of glycosaminoglycans such as heparin for the treatment of respiratory disorders such as copd